Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics

Open access
Vallelian, Florence, Buehler, Paul W., Schaer, Dominik J. · 2022 · Blood

Abstract

During hemolysis, erythrophagocytes dispose damaged red blood cells. This prevents the extracellular release of hemoglobin, detoxifies heme, and recycles iron in a linked metabolic pathway. Complementary to this process, haptoglobin and hemopexin scavenge and shuttle the red blood cell toxins hemoglobin and heme to cellular clearance. Pathological hemolysis outpaces macrophage capacity and scavenger synthesis across a diversity of diseases. This imbalance leads to hemoglobin-driven disease progression. To meet a void in treatment options, scavenger protein-based therapeutics are in clinical development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2022015596

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 85

  1. Schaer, 2013, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, 121, 1276, 10.1182/blood-2012-11-451229 · DOI · Paper page
  2. Morris, 2005, Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease, JAMA, 294, 81, 10.1001/jama.294.1.81 · DOI · Paper page
  3. Reynolds, 1983, Gout and hyperuricemia associated with sickle-cell anemia, Semin Arthritis Rheum, 12, 404, 10.1016/0049-0172(83)90020-3 · DOI
  4. Donadee, 2011, Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion, Circulation, 124, 465, 10.1161/CIRCULATIONAHA.110.008698 · DOI · Paper page
  5. Camus, 2015, Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease, Blood, 125, 3805, 10.1182/blood-2014-07-589283 · DOI · Paper page
  6. Garnier, 2020, Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties, Blood, 136, 247, 10.1182/blood.2020004853 · DOI
  7. Schaer, 2016, Haptoglobin preserves vascular nitric oxide signaling during hemolysis, Am J Respir Crit Care Med, 193, 1111, 10.1164/rccm.201510-2058OC · DOI
  8. Doherty, 1998, Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin, Nat Biotechnol, 16, 672, 10.1038/nbt0798-672 · DOI · Paper page
  9. Hugelshofer, 2019, Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm, J Clin Invest, 129, 5219, 10.1172/JCI130630 · DOI
  10. Schaer, 2013, Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage, Cell Death Differ, 20, 1569, 10.1038/cdd.2013.113 · DOI
  11. Posta, 2020, Hemoglobin oxidation generates globin-derived peptides in atherosclerotic lesions and intraventricular hemorrhage of the brain, provoking endothelial dysfunction, Lab Invest, 100, 986, 10.1038/s41374-020-0403-x · DOI
  12. Potor, 2021, Oxidation of hemoglobin drives a proatherogenic polarization of macrophages in human atherosclerosis, Antioxid Redox Signal, 35, 917, 10.1089/ars.2020.8234 · DOI
  13. Bunn, 1968, Exchange of heme among hemoglobins and between hemoglobin and albumin, J Biol Chem, 243, 465, 10.1016/S0021-9258(18)93628-8 · DOI · Paper page
  14. Nagy, 2010, Red cells, hemoglobin, heme, iron, and atherogenesis, Arterioscler Thromb Vasc Biol, 30, 1347, 10.1161/ATVBAHA.110.206433 · DOI · Paper page
  15. Deuel, 2015, Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity, Free Radic Biol Med, 89, 931, 10.1016/j.freeradbiomed.2015.09.016 · DOI
  16. Deuel, 2016, Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response, Cell Death Dis, 7, e2064, 10.1038/cddis.2015.392 · DOI · Paper page
  17. Balla, 1993, Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage, Proc Natl Acad Sci USA, 90, 9285, 10.1073/pnas.90.20.9285 · DOI · Paper page
  18. Balla, 1991, Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species, Lab Invest, 64, 648
  19. Buehler, 2010, Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives, Antioxid Redox Signal, 12, 275, 10.1089/ars.2009.2799 · DOI
  20. Yalamanoglu, 2018, Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease, Am J Physiol Lung Cell Mol Physiol, 315, L765, 10.1152/ajplung.00269.2018 · DOI
  21. Redinus, 2019, An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease, JCI Insight, 4, e127860, 10.1172/jci.insight.127860 · DOI
  22. Svistunenko, 1997, The globin-based free radical of ferryl hemoglobin is detected in normal human blood, J Biol Chem, 272, 7114, 10.1074/jbc.272.11.7114 · DOI
  23. Baek, 2017, Iron accelerates hemoglobin oxidation increasing mortality in vascular diseased guinea pigs following transfusion of stored blood, JCI Insight, 2, e93577, 10.1172/jci.insight.93577 · DOI
  24. Boretti, 2009, Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs, J Clin Invest, 119, 2271
  25. Bissinger, 2021, Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism, Kidney Int, 100, 1227, 10.1016/j.kint.2021.08.024 · DOI
  26. Minneci, 2005, Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin, J Clin Invest, 115, 3409, 10.1172/JCI25040 · DOI · Paper page
  27. Rother, 2005, The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease, JAMA, 293, 1653, 10.1001/jama.293.13.1653 · DOI · Paper page
  28. Brzoska, 2020, Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles, JCI Insight, 5, e139437, 10.1172/jci.insight.139437 · DOI
  29. Vats, 2020, Platelet extracellular vesicles drive inflammasome-IL-1β-dependent lung injury in sickle cell disease, Am J Respir Crit Care Med, 201, 33, 10.1164/rccm.201807-1370OC · DOI
  30. Vallelian, 2015, Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress, Cell Death Differ, 22, 597, 10.1038/cdd.2014.154 · DOI · Paper page
  31. Martins, 2016, Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions, Nat Immunol, 17, 1361, 10.1038/ni.3590 · DOI · Paper page
  32. James, 2020, Heme induces rapid endothelial barrier dysfunction via the MKK3/p38MAPK axis, Blood, 136, 749, 10.1182/blood.2019003986 · DOI
  33. Ghosh, 2019, P-selectin plays a role in haem-induced acute lung injury in sickle mice, Br J Haematol, 186, 329, 10.1111/bjh.15807 · DOI
  34. Pfefferlé, 2020, Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes, J Clin Invest, 130, 5576, 10.1172/JCI137282 · DOI
  35. Olonisakin, 2021, Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation, J Clin Invest, 131, e7468, 10.1172/JCI137468 · DOI
  36. Klei, 2017, From the cradle to the grave: The role of macrophages in erythropoiesis and erythrophagocytosis, Front Immunol, 8, 73, 10.3389/fimmu.2017.00073 · DOI · Paper page
  37. Bories, 2020, Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway, Blood, 136, 1535, 10.1182/blood.2020004964 · DOI
  38. Kim, 2018, Infused wild-type macrophages reside and self-renew in the liver to rescue the hemolysis and anemia of Hmox1-deficient mice, Blood Adv, 2, 2732, 10.1182/bloodadvances.2018019737 · DOI
  39. Boyle, 2012, Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection, Circ Res, 110, 20, 10.1161/CIRCRESAHA.111.247577 · DOI · Paper page
  40. Seneviratne, 2020, Hematoma resolution in vivo is directed by activating transcription factor 1, Circ Res, 127, 928, 10.1161/CIRCRESAHA.119.315528 · DOI
  41. Pfefferlé, 2021, Acute hemolysis and heme suppress anti-CD40 antibody-induced necro-inflammatory liver disease, Front Immunol, 12, 680855, 10.3389/fimmu.2021.680855 · DOI
  42. Andersen, 2012, Structure of the haptoglobin-haemoglobin complex, Nature, 489, 456, 10.1038/nature11369 · DOI · Paper page
  43. Andersen, 2017, Haptoglobin. Antioxid Redox Signal, 26, 814, 10.1089/ars.2016.6793 · DOI · Paper page
  44. Lipiski, 2013, Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity, Antioxid Redox Signal, 19, 1619, 10.1089/ars.2012.5089 · DOI
  45. Buzzi, 2021, Modular platform for the development of recombinant hemoglobin scavenger biotherapeutics, Mol Pharm, 18, 3158, 10.1021/acs.molpharmaceut.1c00433 · DOI
  46. Buehler, 2009, Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification, Blood, 113, 2578, 10.1182/blood-2008-08-174466 · DOI · Paper page
  47. Cooper, 2013, Haptoglobin binding stabilizes hemoglobin ferryl iron and the globin radical on tyrosine β145, Antioxid Redox Signal, 18, 2264, 10.1089/ars.2012.4547.test · doi:10.1089/ars.2012.4547.test
  48. Vallelian, 2015, Spin trapping combined with quantitative mass spectrometry defines free radical redistribution within the oxidized hemoglobin:haptoglobin complex, Free Radic Biol Med, 85, 259, 10.1016/j.freeradbiomed.2015.04.023 · DOI
  49. Kristiansen, 2001, Identification of the haemoglobin scavenger receptor, Nature, 409, 198, 10.1038/35051594 · DOI · Paper page
  50. Vinchi, 2013, Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases, Circulation, 127, 1317, 10.1161/CIRCULATIONAHA.112.130179 · DOI · Paper page
  51. Muller-Eberhard, 1968, Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases, Blood, 32, 811, 10.1182/blood.V32.5.811.811 · DOI · Paper page
  52. Miller, 1995, The involvement of low-density lipoprotein in hemin transport potentiates peroxidative damage, Biochim Biophys Acta, 1272, 119, 10.1016/0925-4439(95)00075-F · DOI
  53. Miller, 1997, Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin, Biochemistry, 36, 12189, 10.1021/bi970258a · DOI · Paper page
  54. Miller, 1999, Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation, Biochim Biophys Acta, 1454, 153, 10.1016/S0925-4439(99)00027-7 · DOI
  55. Belcher, 2018, Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: role of heme oxygenase-1 induction, PLoS One, 13, e0196455, 10.1371/journal.pone.0196455 · DOI
  56. Gentinetta, 2022, Plasma-derived hemopexin as a candidate therapeutic agent for acute vaso-occlusion in sickle cell disease: preclinical evidence, J Clin Med Res, 11, 630
  57. Hu, 2021, Free hemoglobin ratio as a novel biomarker of acute kidney injury after on-pump cardiac surgery: secondary analysis of a randomized controlled trial, Anesth Analg, 132, 1548, 10.1213/ANE.0000000000005381 · DOI
  58. Alshaikh, 2018, Financial impact of acute kidney injury after cardiac operations in the United States, Ann Thorac Surg, 105, 469, 10.1016/j.athoracsur.2017.10.053 · DOI
  59. Mamikonian, 2014, Cardiopulmonary bypass is associated with hemolysis and acute kidney injury in neonates, infants, and children, Pediatr Crit Care Med, 15, e111, 10.1097/PCC.0000000000000047 · DOI
  60. Graw, 2022, The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO, Crit Care, 26, 50, 10.1186/s13054-022-03894-5 · DOI
  61. Saylor, 2019, Predicting plasma free hemoglobin levels in patients due to medical device-related hemolysis, ASAIO J, 65, 207, 10.1097/MAT.0000000000000801 · doi:10.1097/mat.0000000000000801
  62. Tanaka, 1991, Administration of haptoglobin during cardiopulmonary bypass surgery, ASAIO Trans, 37, M482
  63. Gleason, 2019, Hemoadsorption to reduce plasma-free hemoglobin during cardiac surgery: results of REFRESH I Pilot Study, Semin Thorac Cardiovasc Surg, 31, 783, 10.1053/j.semtcvs.2019.05.006 · DOI
  64. Wetz, 2017, Haptoglobin and free haemoglobin during cardiac surgery-is there a link to acute kidney injury?, Anaesth Intensive Care, 45, 58, 10.1177/0310057X1704500109 · doi:10.1177/0310057x1704500109
  65. Yoshida, 2019, Red blood cell storage lesion: causes and potential clinical consequences, Blood Transfus, 17, 27
  66. D’Alessandro, 2019, Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Heterogeneity of blood processing and storage additives in different centers impacts stored red blood cell metabolism as much as storage time: lessons from REDS-III-Omics, Transfusion, 59, 89, 10.1111/trf.14979 · doi:10.1111/trf.14979
  67. Nemkov, 2021, Blood donor exposome and impact of common drugs on red blood cell metabolism, JCI Insight, 6, e146175, 10.1172/jci.insight.146175 · DOI
  68. Risbano, 2015, Effects of aged stored autologous red blood cells on human endothelial function, Am J Respir Crit Care Med, 192, 1223, 10.1164/rccm.201501-0145OC · DOI
  69. Hod, 2010, Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation, Blood, 115, 4284, 10.1182/blood-2009-10-245001 · DOI · Paper page
  70. de Wolski, 2016, Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells, Haematologica, 101, 578, 10.3324/haematol.2015.139139 · DOI
  71. Wang, 2014, Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia, Transfusion, 54, 1712, 10.1111/trf.12607 · DOI
  72. Hod, 2011, Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron, Blood, 118, 6675, 10.1182/blood-2011-08-371849 · DOI · Paper page
  73. Buehler, 2018, When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells?, Curr Opin Hematol, 25, 452, 10.1097/MOH.0000000000000458 · DOI
  74. Graw, 2016, Haptoglobin or hemopexin therapy prevents acute adverse effects of resuscitation after prolonged storage of red cells, Circulation, 134, 945, 10.1161/CIRCULATIONAHA.115.019955 · DOI
  75. Wagener, 2018, Role of heme in lung bacterial infection after trauma hemorrhage and stored red blood cell transfusion: a preclinical experimental study [published correction appears in PLoS Med. 2019;16(11):e1002991], PLoS Med, 15, e1002522, 10.1371/journal.pmed.1002522 · DOI
  76. Akeret, 2021, Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury, J Cereb Blood Flow Metab, 41, 3000, 10.1177/0271678X211020629 · DOI
  77. Garland, 2020, Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin, Brain Commun, 2, fcz053, 10.1093/braincomms/fcz053 · DOI
  78. Jayle, 1946, Action of haptoglobin on the peroxidase catalysis of hemoglobin; new theory on the constitution of enzymes [in Italian], ull Soc Chim Biol (Paris), 28, 63
  79. Connell, 1962, Subdivision of the three common haptoglobin types based on ‘hidden’ diffrences, Nature, 193, 505, 10.1038/193505a0 · doi:10.1038/193505a0
  80. Smithies, 1962, Inheritance of haptoglobin subtypes, Am J Hum Genet, 14, 14
  81. Bunn, 1969, The renal handling of hemoglobin. I. Glomerular filtration, J Exp Med, 129, 909, 10.1084/jem.129.5.909 · DOI · Paper page
  82. Bunn, 1969, The renal handling of hemoglobin. II. Catabolism, J Exp Med, 129, 925, 10.1084/jem.129.5.925 · doi:10.1084/jem.129.5.925
  83. Paoli, 1999, Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains, Nat Struct Biol, 6, 926, 10.1038/13294 · DOI
  84. Schaer, 2018, Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobin-binding therapeutics, BMC Biotechnol, 18, 15, 10.1186/s12896-018-0424-3 · DOI
  85. Karnaukhova, 2021, Human plasma and recombinant hemopexins: heme binding revisited, Int J Mol Sci, 22, 1199, 10.3390/ijms22031199 · DOI

Metadata

Authors
Vallelian, F., Buehler, P. W., & Schaer, D. J.
Venue
Blood
Published
2022-10-27
Volume
140
Issue
17
Pages
1837-1844
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W4281962215
Cited by
167
References
20
FWCI
13.34
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics. https://app.cochat.ai/papers/10.1182/blood.2022015596
The paper
Vallelian, F., Buehler, P. W., & Schaer, D. J. (2022). Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics. Blood. https://doi.org/10.1182/blood.2022015596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.